Downloadable Slidesets

Share

Program Content

Activities

  • Frontline Therapy for CLL
    Optimal Selection of Therapy for Treatment-Naive CLL
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 08, 2021

    Expires: June 07, 2022

  • Treating R/R CLL
    State of the Art Management in Relapsed/Refractory CLL
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 08, 2021

    Expires: June 07, 2022

  • Future Directions in CLL
    Near Future Directions: Promising Agents and Combinations Under Investigation
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 08, 2021

    Expires: June 07, 2022

  • <i>EP</i>: State-of-the-Art in CLL
    ExpressPoints
    Guideline Updates and Real-World Experiences in CLL: State-of-the-Art Evidence and Next Questions
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 15, 2021

    Expires: June 14, 2022

Faculty

cover img faculity

Jeremy S Abramson, MD, MMSc

Director, Center for Lymphoma
Mass General Cancer Center
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

cover img faculity

Anthony Mato, MD, MSCE

Associate Professor
Division of Leukemia
Memorial Sloan Kettering Cancer Center
New York, New York

cover img faculity

William G. Wierda, MD, PhD

Associate Professor of Medicine
Department of Leukemia
The University of Texas
M.D. Anderson Cancer Center
Houston, Texas

Provided by

ProCE Banner

Provided by the National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC

Supporters

Supported by educational grants from

AbbVie

AstraZeneca

BeiGene, Ltd.

Lilly

Pharmacyclics LLC and Janssen